Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00098462
Status:
WITHDRAWN
Last Update Posted:
2012-10-04
First Post:
2004-12-07
Brief Title:
Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor:
Jonsson Comprehensive Cancer Center
Organization:
Jonsson Comprehensive Cancer Center
Organization Data
Organization:
Jonsson Comprehensive Cancer Center
Class:
OTHER
Study ID:
CDR0000401501
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jonsson Comprehensive Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |